The use of chimeric human Fcε receptor I to redirect cytotoxic T lymphocytes to tumors

Journal of Leukocyte Biology

Volumn 60, Issue 6, 1996, Pages 721-728

  Kershaw, Michael H ^a   Darcy, Phillip K ^a   Trapani, Joseph A ^a   Smyth, Mark J ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

5' promoter; cytotoxicity; Fc receptor; IgE

Indexed keywords

CHIMERIC RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 0030468940     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.6.721     Document Type: Article

References (26)

1. Trinchieri, G. (1989) Biology of natural killer cells. Adv. Immunol. 47, 187-376.
2. Whileside, T. L., Herberman, R. B. (1994) The role of natural killer cells in immune surveillance of cancer. Curr. Op. Immunol. 7, 704-710.
3. Robertson, M. J., Ritz, J. (1990) Biology and relevance of natural killer cells. Blood 76, 2421-2438.
4. Rosenberg, S. A. (1992) Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10, 180-199.
5. Topalian, S. L., Rosenberg, S. A. (1990) Tumor infiltrating lymphocytes (TIL): evidence for specific immune reactions against growing cancers in mouse and man. In Important Advances in Oncology. (V. DeVita, S. Hell-man, S. A. Rosenberg, eds.), Philadelphia, Lipincott, 19-41.
6. Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian. S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson. C. G., Carter. C., Bock, S., Schwartzentruber, D., Wei, J. P., White, D. E. (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. N. Engl. J. Med. 319, 1676-1680.
7. Smyth, M. J., Kershaw, M. H. (1995) Cytotoxic lymphocyte-mediated therapy. Aust. N. Z. J. Med. 25, 852-858.
8. Topalian, S. L., Kasid, A., Rosenberg, S. A. (1990) Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures. J. Immunol. 144, 4487-4495.
9. Perez, P., Hoffman, R. W., Shaw, S., Bluestone, J. A., Segal, D. M. (1985) Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody. Nature 316, 354-356.
10. Fanger, M. W., Segal, D. M., Romet-Lemonne, J-L. (1991) Bispecific antibodies and targeted cellular cytotoxicity. Immunol. Today 12, 51-54.
11. Romeo, C., Seed, B. (1991) Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell 64, 1037-1046.
12. Gross, G., Eshhar, Z. (1992) Endowing T cells with antibody-specificity using chimeric T cell receptors. FASEB J. 6, 3370-3378.
13. Eshhar, Z., Waks, T., Gross, G., Schindler, D. G. (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. USA 90, 720-724.
14. Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S. M., Lee, T., Pope, S. H., Riordan, G. S., Whitlow, M. (1988) Single chain antigen-binding proteins. Science 242, 423-426.
15. Ravetch, J. V., Kinet, J-P. (1991) Fc receptors. Annu. Rev. Immunol. 9, 457-492.
16. Metzger, H., Alcaraz, G., Hohman, R., Kinet, J-P., Pribluda, V., Quarto, R. (1986) The receptor with high affinity for immunoglobulin E. Annu. Rev. Immunol. 4, 419-470.
17. Kershaw, M. H., Darcy, P., Hulett, M. D., Hogarth, P. M., Trapani, J. A., Smyth, M. J, (1996) Redirecting cytotoxic function: requirements for expression of chimeric single chain high affinity IgE receptors. J. Biol. Chem., 271, 21214-21225.
18. Palladino, M. A., Obata, Y., Stocken, E., Oettgen, H. F. (1983) Characterization of interleukin-2 dependent cytotoxic T-cell clones: specificity, cell surface phenotype and susceptibility to blocking by Lyt 2 antisera. Cancer Res. 43, 572-576.
19. Smyth, M. J., Pietersz, G. A., McKenzie, I. F. C. (1986) The specific targeting of chlorambucil to tumors. J. Natl. Cancer Inst. 76, 503-510.
20. Isaacs, J. D., Clark, M. R., Greenwood, J., Waldmann, H. (1992) Therapy with monoclonal antibodies. An in vivo model for assessment of therapeutic potential. J. Immunol. 148, 3062-3071.
21. Smyth, M. J., O'Connor, M. D., Kelly, J. M., Ganesvaran, S., Trapani, J. (1995) Expression of recombinant human Met-ase-1: a NK cell-specific granzyme. Biochem. Biophys. Res. Comm. 217, 675-683.
22. Lichtenheld, M. G., Podack, E. R., Levy, R. B. (1995) Transgenic control of perforin gene expression. Functional evidence for two separate control regions. J. Immunol. 154, 2153-2163.
23. Moritz, D., Wels, W., Mattern, J., Groner, B. (1994) Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Proc. Natl. Acad. Sci. USA 91, 4318-4322.
24. Mule, J. J., Shu, S., Schwartz, S. L., Rosenberg, S. A. (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225, 1487-1489.
25. Rosenberg, S. A., Spiess, P., LaFreniere, R. (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233, 1318-1321.
26. Smyth. M. J., Kershaw, M. H., Hulett, M. D., McKenzie, I. F. C., Trapani, J. A. (1994) The 5′ flanking region of the murine perforin gene targets expression of a human Fc γ receptor I to cytotoxic T lymphocytes. J. Leukoc. Biol. 55, 514-522.